TransMedics Group (TMDX) Tops Q2 EPS by 47c ; Offers Guidance

TransMedics Group (NASDAQ: TMDX) reported Q2 EPS of $0.92, $0.47 better than the analyst estimate of $0.45. Revenue for the quarter came in at $157.4 million versus the consensus estimate of $146.74 million.

GUIDANCE:

TransMedics Group sees FY2025 revenue of $585-605 million, versus the consensus of $582.1 million.

For earnings history and earnings-related data on TransMedics Group (TMDX) click here.

You May Also Be Interested In

• Crude Inventory Rose 2.97 Million Barrels Last Week - EIA
• Paychex (PAYX) Tops Q1 EPS by 2c
• Sirius XM (SIRI) call put ratio 11 calls to 1 put with a focus on 1600 contracts of June 40 calls